EGFR and neoplasm: Angiotensin receptor-1 (ATR1) signalling appears to be the major component of RAAS involved in tumour growth (by inducing angiogenesis) and tumour proliferation (by promoting vascular or epidermal growth factor receptor expression) [33, 35].